Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p18
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 18/36)
Character Range: 359988–363304

use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or

       (c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (f) in preparations containing 25% or less of eugenol.
    FAMOXADONE.
    FAMPHUR in preparations containing 20% or less of famphur.
    FEBANTEL except:

       (a) in divided preparations containing 1000 mg or less of febantel per dosage unit; or

       (b) in undivided preparations containing 10% or less of febantel.
    FENAMIPHOS in granular preparations containing 5% or less of fenamiphos.
    FENAZAFLOR.
    FENBUTATIN OXIDE.
    FENCHLORPHOS.
    FENITROTHION.
    FENOXACRIM in preparations for the treatment of carpets during manufacture.
    FENPROPIDIN.
    FENPYROXIMATE.
    FENTHION in preparations containing 60% or less of fenthion except when included in Schedule 5.
    FENVALERATE.
    FIPRONIL except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 0.05% or less of fipronil.
    FLOCOUMAFEN in preparations containing 0.005% or less of flocoumafen.
    FLONICAMID.
    FLUAZAINDOLIZINE except when included in Schedule 5.
    FLUAZIFOP‑BUTYL.
    FLUAZIFOP‑p‑BUTYL.
    FLUAZINAM.
    FLUCOFURON in preparations for the treatment of carpets during manufacture.
    FLUENSULFONE.
    FLUMETHRIN except when included in Schedule 5.
    FLUMIOXAZIN when contained in water soluble bags individually packed in sealed sachets.
    FLUORIDES except:

       (a) when included in Schedule 5; or

       (b) in preparations for human use; or

       (c) in preparations containing 15 mg/kg or less of fluoride ion.
    FLUPROPANATE.
    FLUPYRADIFURONE.
    FLUQUINCONAZOLE.
    FLUSILAZOL.
    FLUTRIAFOL except in fertilisers containing 0.5% or less of flutriafol.
    FLUVALINATE except when included in Schedule 5.
    FOMESAFEN SODIUM.
    FORMALDEHYDE (excluding its derivatives) in preparations containing 0.05% or more of free formaldehyde except:

       (a) for human therapeutic use; or

       (b) in oral hygiene preparations; or

       (c) in nail hardener cosmetic preparations containing 5% or more of free formaldehyde; or

       (d) in nail hardener cosmetic preparations containing 0.2% or less of free formaldehyde when labelled with the statement:

           PROTECT CUTICLES WITH GREASE OR OIL;

       (e)